33.23
0.48 (1.47%)
| Penutupan Terdahulu | 32.75 |
| Buka | 32.92 |
| Jumlah Dagangan | 78,486 |
| Purata Dagangan (3B) | 655,279 |
| Modal Pasaran | 1,509,835,648 |
| Harga / Pendapatan (P/E TTM) | 830.75 |
| Harga / Jualan (P/S) | 1.30 |
| Harga / Buku (P/B) | 1.22 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 7 May 2026 |
| Margin Keuntungan | 1.87% |
| Margin Operasi (TTM) | -4.31% |
| EPS Cair (TTM) | 0.460 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | 9.60% |
| Pertumbuhan Pendapatan Suku Tahunan (YOY) | 55.40% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 30.69% |
| Nisbah Semasa (MRQ) | 1.38 |
| Aliran Tunai Operasi (OCF TTM) | 163.69 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | 122.12 M |
| Pulangan Atas Aset (ROA TTM) | 0.35% |
| Pulangan Atas Ekuiti (ROE TTM) | 1.73% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Health Information Services (US) | Menurun | Menurun |
| Health Information Services (Global) | Menurun | Menurun | |
| Stok | Omnicell, Inc. | Menaik | Menaik |
AISkor Stockmoo
| Konsensus Penganalisis | 3.0 |
| Aktiviti Orang Dalam | -1.5 |
| Volatiliti Harga | -2.0 |
| Purata Bergerak Teknikal | 2.5 |
| Osilator Teknikal | -0.5 |
| Purata | 0.30 |
|
Omnicell Inc provides automation and business analytics software for healthcare providers. The company is engaged in transforming the pharmacy and nursing care delivery model. The company helps its customers define and deliver cost-effective medication management designed to equip and empower pharmacists and nurses to focus on patient care rather than administrative tasks and drive improved clinical, operational, and financial outcomes across all care settings. The company derives the majority of its revenue from the United States. |
|
| Sektor | Healthcare |
| Industri | Health Information Services |
| Gaya Pelaburan | Small Core |
| % Dimiliki oleh Orang Dalam | 1.78% |
| % Dimiliki oleh Institusi | 104.60% |
Pemilikan
| Nama | Tarikh | Syer Dipegang |
|---|---|---|
| Cadian Capital Management, Lp | 31 Dec 2025 | 1,142,555 |
| Julat 52 Minggu | ||
| Julat Harga Sasaran | ||
| Tinggi | 60.00 (Benchmark, 80.56%) | Beli |
| 60.00 (Keybanc, 80.56%) | Beli | |
| Median | 56.00 (68.52%) | |
| Rendah | 49.00 (Piper Sandler, 47.46%) | Beli |
| Purata | 55.25 (66.27%) | |
| Jumlah | 4 Beli | |
| Harga Purata @ Panggilan | 45.82 | |
| Syarikat | Tarikh | Harga Sasaran | Panggilan | Harga @ Panggilan |
|---|---|---|---|---|
| Piper Sandler | 06 Feb 2026 | 49.00 (47.46%) | Beli | 37.07 |
| Benchmark | 02 Feb 2026 | 60.00 (80.56%) | Beli | 48.70 |
| Keybanc | 08 Jan 2026 | 60.00 (80.56%) | Beli | 50.59 |
| Wells Fargo | 05 Jan 2026 | 52.00 (56.49%) | Beli | 46.93 |
Tiada data dalam julat masa ini.
| Tarikh | Jenis | Butiran |
|---|---|---|
| 05 Feb 2026 | Pengumuman | Omnicell Announces Fiscal Year and Fourth Quarter 2025 Financial Results |
| 13 Jan 2026 | Pengumuman | Omnicell to Release Fourth Quarter and Full Year 2025 Financial Results on February 5, 2026 |
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |